Viewing Study NCT01619332


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-05-27 @ 7:12 AM
Study NCT ID: NCT01619332
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2012-06-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type II Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy volunteers, View
None Diabetes View
None Glucose View
None Pharmacokinetics View